col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


186 Results       Page 1

 [1] 
Elsevier: Digestive and Liver Disease
  original article Date Title Authors   All Authors
1 [GO] 2024―Apr―10 T.12.5: MECHANISTIC ANALYSIS OF FACTORS ASSOCIATED WITH POST COVID-19 IBS OCCURRENCE K. Hod, G. Marasco, C. Cremon, M.R. Barbaro, L. Colecchia, A. Kagramanova, et al. (+27)
2 [GO] 2024―Apr―10 T.02.8: PRIORITIZE STUDY: PRIORITIZING RESUMPTION OF COLORECTAL SCREENING AFTER COVID PANDEMIC S. Pecere, L. Frazzoni, C. Hassan, L.E. Del Vecchio, C. Fabbri, F. Iacopini, et al. (+5)
3 [GO] 2024―Apr―08 Corrigendum to “Telemedicine in inflammatory bowel disease from its origin to the post pandemic golden age: A narrative review” [Digestive and Liver Disease, Volume 56, Issue 1, January 2024, Pages 1-6] Massimo Claudio Fantini, Erica Loddo, Amalia Di Petrillo, Sara Onali
4 [GO] 2024―Jan―21 OC.11.4 ITALIAN SOCIETY FOR DIGESTIVE DISEASES ACCREDITATION PROGRAM DURING COVID-19 PANDEMIC: RESULTS IN REMOTE REACCREDITATION IN 15 CENTRES G. Spinzi, P. Da Massa Carrara, V. Boarino, P. Brosolo, T. Iannone, A. Merighi, et al. (+4)
5 [GO] 2023―Jun―15 Telemedicine in inflammatory bowel disease from its origin to the post pandemic golden age: A narrative review Massimo Claudio Fantini, Erica Loddo, Amalia Di Petrillo, Sara Onali
6 [GO] 2023―Mar―23 T.01.2 NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING (NVUGIB): HOW DID COVID-19 IMPACT ON HOSPITALIZATIONS AND 30-DAY MORTALITY IN VENETO REGION? B. Germana, L. Salmaso, S. Bellio, U. Fedeli, M. Saia
7 [GO] 2023―Mar―23 OC.14.2 LACK OF SEROCONVERSION FOLLOWING COVID-19 VACCINATION, BUT NOT TREATMENT, IS AN INDEPENDENT RISK FACTOR FOR BREAKTHROUGH SARS-COV-2 INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE - AN IGIBD STUDY F.S. Macaluso, M. Principi, F. Facciotti, A. Contaldo, A. Todeschini, S. Saibeni, et al. (+23)
8 [GO] 2023―Mar―23 T.03.3 THE INFLUENCE OF SUPERIMPOSED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-COV-2) LIFESTYLE CHANGES ON NON-ALCOHOLIC FATTY LIVER DISEASE EVOLUTION: A MATTER OF BODY COMPOSITION: A MULTICENTER CLINICAL STUDY M. Romeo, M. Cipullo, G. Zagaria, L. Ventriglia, F. Scognamiglio, G. Iadanza, et al. (+6)
9 [GO] 2023―Mar―23 OC.14.1 SARS-COV-2 INFECTION DOES NOT WORSEN THE COURSE OF INFLAMMATORY BOWEL DISEASE IN THE LONG TERM B. Neri, G. D'Agostini, S. Salvatori, M. Mossa, F. Bettin, I. Marafini, et al. (+4)
10 [GO] 2023―Mar―23 T.06.7 THE BURDEN OF SARS-COV-2 PANDEMIC ON COLORECTAL CANCER SCREENING PROGRAM DELAY: DATA FROM A LARGE SCREENING CENTRE IN CAMPANIA N. Imperatore, G. Cordone, L. Martorelli, M. Avellino, D. Musto, V. Familiari, et al. (+3)
11 [GO] 2023―Mar―23 OC.05.6 HELICOBACTER PYLORI AND SARS-COV-2: A DANGEROUS PATHOGENETIC CORRELATION? F. Termite, G. Gasbarrini, S. Simeoni, F. Bonvicini
12 [GO] 2023―Mar―09 Medium-term outcome of liver recipients from COVID-19 donors M. Saracco, D. Cocchis, F. Tandoi, F. Rigo, R. Romagnoli, S. Martini
13 [GO] 2023―Mar―09 Omicron SARS-CoV-2 variant outbreak in vaccinated liver transplant (LT) recipients in 2022: A large spread of infection, a mild disease M.F. Donato, C. Dibenedetto, E. Farina, A. Toppetta, S.C. Uceda Renteria, C. Rigamonti, et al. (+6)
14 [GO] 2023―Mar―03 Where are the non-celiac gluten-sensitive patients gone? The COVID-19 effect Carolina Ciacci, Francesco Valitutti
15 [GO] 2023―Jan―17 The natural history of COVID-19 in vaccinated inflammatory bowel disease patients N. Viazis, I. Drygiannakis, K. Karmiris, A. Theodoropoulou, E. Zampeli, M. Tzouvala, et al. (+20)
16 [GO] 2023―Jan―16 Biodegradable biliopancreatic stents could help conserve health care resources during the COVID-19 pandemic: An observational multicenter study Andreas Maieron, Lukas Erhart, Patricia Pramhofer, Rainer Schöfl, Georg Spaun, Emanuel Steiner, et al. (+2)
17 [GO] 2023―Jan―05 Multiple benefits of implementing a hepatology rapid access clinic highlighted by the COVID-19 pandemic Mirela Chitul, Ji Jade King, Andrei Chitul, Paul Balanescu, Aruna Dias
18 [GO] 2022―Dec―16 COVID-19 vaccination among cirrhotics in Italy: High coverage and effectiveness of 3 doses versus 2 in preventing breakthrough infection and hospitalization Tommaso Stroffolini, Alessia Ciancio, Alessandro Federico, Rosa G. Benigno, Guido Colloredo, Anna Lombardi, et al. (+5)
19 [GO] 2022―Nov―26 Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis Amnuay Keebayoon, Viroj Wiwanitkit
20 [GO] 2022―Oct―29 Reply to Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease” Fabio Salvatore Macaluso, Ambrogio Orlando
21 [GO] 2022―Oct―18 Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study” Pathum Sookaromdee, Viroj Wiwanitkit
22 [GO] 2022―Oct―17 Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis: A prospective single center study Massimo Iavarone, Giulia Tosetti, Floriana Facchetti, Matilde Topa, Joey Ming Er, Shou Kit Hang, et al. (+14)
23 [GO] 2022―Oct―10 Artificial intelligence and big data processing for the development of predictive models to support Covid-19 hospital patients L. Miele, M. Dajko, M.C. Savino, V. Calvez, N.D. Capocchiano, A. Liguori, et al. (+5)
24 [GO] 2022―Sep―29 Chronic liver disease-related mortality in diabetes before and during the COVID-19 in the United States Donghee Kim, Omar Alshuwaykh, Brittany B. Dennis, George Cholankeril, Joshua W. Knowles, Aijaz Ahmed
25 [GO] 2022―Sep―06 Intentional Treatment with Tofacitinib in a patient with severe refractory Ulcerative Colitis and concomitant Sars-CoV-2 infection Stefano Festa, Fabiola De Biasio, Annalisa Aratari, Claudio Papi
26 [GO] 2022―Aug―29 Reduced Humoral Response to Two Doses of COVID-19 Vaccine in Patients with Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD study Fabio Salvatore Macaluso, Mariabeatrice Principi, Federica Facciotti, Antonella Contaldo, Alessia Todeschini, Simone Saibeni, et al. (+38)
27 [GO] 2022―Aug―13 Therapeutic adherence recorded in the outpatient follow-up of inflammatory bowel diseases in a referral center: Damages of COVID-19 Raffaele Pellegrino, Gianluca Pellino, Francesco Selvaggi, Alessandro Federico, Marco Romano, Antonietta Gerarda Gravina
28 [GO] 2022―Aug―04 Covid-19 and alcohol associated liver disease Sasha Deutsch-Link, Brenda Curtis, Ashwani K. Singal
29 [GO] 2022―May―04 OC.15.2 HUMORAL RESPONSE TO 2-DOSE BNT162B2 MRNA VACCINE FOR COVID-19 IN LIVER TRANSPLANT RECIPIENTS M. Guarino, I. Esposito, G. Portella, V. Cossiga, I. Loperto, L. Pignata, et al. (+11)
30 [GO] 2022―May―04 OC.08.1 THE IMPACT OF THE COVID-19 PANDEMIC ON HOSPITALIZATIONS FOR DIVERTICULAR DISEASE B. Germana’, C. Barbiellini Amidei, S. Bellio, M. Saia
31 [GO] 2022―May―04 T.04.10 EFFECT OF WHEY PROTEINS ON MALNUTRITION AND EXTUBATING TIME OF CRITICALLY ILL COVID-19 PATIENTS G. Fabiano, E. Scarpellini, M. Scarcella, A. Ascani, M. Zanetti, F. Luzza, L. Abenavoli
32 [GO] 2022―May―04 T.05.10 SAFETY AND FEASIBILITY OF OUTPATIENT ENDOSCOPIC FULLTHICKNESS RESECTION FOR COLORECTAL LESIONS: GET A CLEAR SKY FROM THE COVID-19 STORM M. Gagliardi, C. Abbatiello, M. Fusco, O. Labianca, M. Sica, C. Zulli, A. Maurano
33 [GO] 2022―May―04 OC.02.1 SAFETY OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA OF A NATIONAL STUDY (ESCAPE-IBD) A. Todeschini, A. Contaldo, F.S. Macaluso, F. Facciotti, F. Castiglione, O.M. Nardone, et al. (+16)
34 [GO] 2022―May―04 PC.01.4 REDUCED IMMUNE RESPONSE INDUCED BY TWO DOSES OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE - AN IG-IBD STUDY F.S. Macaluso, M. Principi, F. Facciotti, A. Contaldo, A. Todeschini, S. Saibeni, et al. (+20)
35 [GO] 2022―May―04 T.08.5 THE OVERALL SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) PANDEMIC IMPACT ON METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE. A PRELIMINARY EVALUATION M. Romeo, M. Dallio, M. Cipullo, S. Olivieri, G. Iadanza, M. Sangineto, et al. (+3)
36 [GO] 2022―May―04 OC.10.2 A SERUM METABOLOMICS ANALYSIS TO UNDERSTAND THE INTERPLAY BETWEEN BIOLOGICAL THERAPIES IN IBD PATIENTS AND SUSCEPTIBILITY TO SARS-COV-2 INFECTION L.F. Pisani, S. Mola, G. Crespi, F. Caprioli, M. Annunaziata, M. Manfredi, et al. (+2)
37 [GO] 2022―May―04 OC.02.2 REDUCED EXPRESSION OF SARS-COV-2 INFECTION-RELATED GENES IN INFLAMMATORY BOWEL DISEASE PATIENTS L.F. Pisani, S. Mola, G. Crespi, F. Caprioli, M. Annunziata, C. Porta, L. Pastorelli
38 [GO] 2022―May―04 T.07.7 INCREASED NUMBER OF COLORECTAL INTERVAL CANCERS IN LYNCH SYNDROME AFTER THE SARS-COV-2 PANDEMIC. A SURVEY-BASED STUDY A. Mannucci, M. Puzzono, M. Russo, A. Barchi, R.A. Zuppardo, P. Biamonte, et al. (+10)
39 [GO] 2022―May―04 T.06.3 DOES SARS-COV-2 VACCINATION AFFECT THE COURSE OF INFLAMMATORY BOWEL DISEASE IN PATIENTS ON BIOLOGICAL THERAPY? F. De Blasio, M. Montori, F. Martini, L. Paolucci, T. Vitalini, G. Pieroni, et al. (+2)
40 [GO] 2022―May―04 T.03.7 PRELIMINARY RESULTS ON SARS-COV-2 VACCINATION RESPONSE IN PATIENTS WITH COELIAC DISEASE AND NON-COELIAC ENTEROPATHIES: A SINGLE-CENTRE CASE-CONTROL STUDY D. Scalvini, A. Schiepatti, S. Maimaris, R. Muscia, V. Gregorio, E. Cosentini, et al. (+3)
41 [GO] 2022―May―04 T.03.10 HENOCH-SCHONLEIN PURPURA FOLLOWING EXPOSURE TO SARS-COV2 MRNA VACCINE: A CASE REPORT F. Di Vincenzo, M. Pizzoferrato, S. Bibbò, S. Ennas, S. Porcari, G. Cammarota
42 [GO] 2022―May―04 OC.08.3 IMPACT OF ENVIRONMENTAL CHANGES FORCED BY PANDEMIC RESTRICTIVE MEASURES ON THE DEVELOPMENT AND COURSE OF IRRITABLE BOWEL SYNDROME S. Kayali, M. Furnari, S. Ziola, E. Giuliana, E. Casagrande, A. Djahandideh, et al. (+5)
43 [GO] 2022―May―04 T.07.6 PATIENTS REFERRED TO ANORECTAL MANOMETRY BEFORE AND DURING THE COVID PANDEMIC: ARE THEY DIFFERENT? C. Lambiase, F. Rettura, A. Pancetti, R. Morganti, G. Berti, F. Baiano Svizzero, et al. (+4)
44 [GO] 2022―Apr―11 Have telephone reminders been a good way to reduce non-attendance rates for endoscopy during the COVID-19 pandemic? Nicoletta Nandi, Elisa Farina, Laura Visconti, Paolo Canté, Luca Elli, Roberto Penagini
45 [GO] 2022―Mar―22 Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis Deepak James, Anuraag Jena, Pardhu Neelam Bharath, Arup Choudhury, Anupam K. Singh, Shaji Sebastian, Vishal Sharma
46 [GO] 2022―Mar―21 Metabolic dysfunction-associated fatty liver disease and liver fibrosis score in patients with COVID-19 as predictors of adverse clinical outcomes: an artificial intelligent application through machine learning A. Dalbeni, M. Zoncapè, M. Carlin, M. Bicego, A. Simonetti, V. Ceruti, et al. (+9)
47 [GO] 2022―Mar―21 Expert consensus criteria and practical recommendations for pbc care in the covid-19 era and beyond M. Berenguer, A.E. Kremer, G. Hirschfield, D. Jones, V. Leroy, F. Adekunle, M. Carbone
48 [GO] 2022―Mar―21 Humoral response to 2-dose BNT162b2 mRNA vaccine for Covid-19 in liver transplant recipients M. Guarino, I. Esposito, G. Portella, V. Cossiga, I. Loperto, L. Pignata, et al. (+11)
49 [GO] 2022―Mar―21 Impact of deterioration of lifestyle and PNPLA3 genotype in NALFD patients during COVID-19 lockdown F. Cinque, A. Cespiati, R. Lombardi, P. Francione, G. Maffi, F. Alletto, et al. (+8)
50 [GO] 2022―Mar―21 Implementation of hcv screening in the 1969-1989 birth-cohort undergoing covid-19 vaccination: a pivotal study in Italy R. D'Ambrosio, G. Rizzardini, M. Puoti, S. Fagiuoli, M.P. Anolli, C. Gabiati, et al. (+5)
51 [GO] 2022―Mar―21 SARS-CoV-2 infection in liver transplantation is associated with favorable outcomes: an Italian transplant registry study M. Rendina, M. Barone, S. Trapani, L. Masiero, P. Trerotoli, F. Puoti, et al. (+49)
52 [GO] 2022―Mar―21 Humoral, cellular, clinical responses and safety of two doses of SARS-CoV-2 Messenger RNA vaccine in patients with compensated and decompensated cirrhosis: a long-term single center prospective study M. Iavarone, G. Tosetti, F. Facchetti, M. Topa, A. Lombardi, R. D'Ambrosio, et al. (+9)
53 [GO] 2022―Mar―21 Clinical features of patients with new onset of autoimmune hepatitis following SARS-CoV-2 vaccination C. Rigamonti, B. Coco, M. Brunetto, S. Labanca, E.G. Giannini, B. Magro, et al. (+8)
54 [GO] 2022―Mar―21 Longevity of seropositivity after anti SARS-CoV-2 vaccination in patients awaiting liver transplant A. Calleri, M. Saracco, R. Romagnoli, S. Martini
55 [GO] 2022―Mar―21 Screening for HCV infection combined with SARS-CoV-2 vaccination in the Campania region P. Torre, M. Annunziata, R. Sciorio, R. Coppola, L. Staiano, C. Coppola, et al. (+2)
56 [GO] 2022―Mar―09 Impact of COVID-19 pandemic on pediatric endoscopy: a multicenter study on behalf of the SIGENP Endoscopy Working Group Sara Renzo, Luca Scarallo, Luca Maria Antoniello, Matteo Bramuzzo, Andrea Chiaro, Fabio Cisarò, et al. (+26)
57 [GO] 2022―Feb―14 Gastrointestinal sequelae among COVID-19 patients after discharge and their predictors Jayanta Samanta, Seerat Singh, Sanjay Kumar, Megha Sharma, Rakesh Kochhar
58 [GO] 2022―Jan―31 Role of the multidisciplinary team in pandemics: A new opportunity to achieve greater immunization in patients with inflammatory bowel disease Paulina Núñez, Rodrigo Quera, Lilian Flores, Raúl Araya, Andrea Córdova, Ismael Correa
59 [GO] 2022―Jan―12 LIVER HISTOPATHOLOGICAL CHANGES AND COVID-19: WHAT DOES LITERATURE HAVE TO TELL US? Jorge Lucas de Sousa Moreira, Sarah Maria Bacurau Barbosa, Jacyanne Gino Vieira, Nicolly Castelo Branco Chaves, Jucier Gonçalves Júnior
60 [GO] 2021―Dec―27 Hepatocellular liver injury in hospitalized patients affected by COVID-19: presence of different risk factors at different time points M. Leo, A. Galante, A. Pagnamenta, L. Ruinelli, F.R. Ponziani, A. Gasbarrini, A. De Gottardi
61 [GO] 2021―Oct―04 Effect of lockdown on digestive system cancer care among older patients during the first wave of COVID-19: the CADIGCOVAGE multicentre cohort study Thomas Aparicio, Richard Layese, François Hemery, Christophe Tournigand, Elena Paillaud, Nicola De Angelis, et al. (+7)
62 [GO] 2021―Sep―20 OC.06.7 LOWER INCIDENCE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH NON-GUT SELECTIVE BIOLOGIC THERAPY F. Ferretti, R. Cannatelli, M.C. Monico, A.M. Carvalhas Gabrielli, S. Carmagnola, G. Maconi, S. Ardizzone
63 [GO] 2021―Sep―20 AF.93 COVID-19 IN LIVER TRANSPLANT RECIPIENTS: AN ITALIAN CASE-CONTROL DOUBLE-CENTER STUDY M. Guarino, V. Cossiga, I. Loperto, I. Esposito, R. Ortolani, A. Fiorentino, et al. (+8)
64 [GO] 2021―Sep―20 OC.04.1 HIGH LEVELS OF TRANSAMINASES AT ADMISSION PREDICT A SEVERE DISEASE COURSE IN COVID-19 HOSPITALIZED PATIENTS F. Pelizzaro, M.P. Kitenge, F. Maran, E. Cocconcelli, E. Balestro, P. Spagnolo, et al. (+2)
65 [GO] 2021―Sep―20 AF.157 EUS-GUIDED GALLBLADDER DRAINAGE: A VALUABLE OPTION IN THE COVID-19 ERA E. Armellini, M.O. Brizi, F. Macchini, M. Marini, F. Rubertà, L. Vescovi, et al. (+2)
66 [GO] 2021―Sep―20 OC.02.9 IMPACT OF COVID-19 OUTBREAK ON GASTRO-INTESTINAL CANCER BURDEN S.M. Milluzzo, E.V. Pesatori, C. Hassan, N. Olivari, L. Minelli Grazioli, P. Cesaro, et al. (+2)
67 [GO] 2021―Sep―20 OC.01.3 NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING HOSPITALIZATION DURING THE FIRST PHASE OF THE COVID-19 PANDEMIC IN VENETO REGION B. Germana”, S. Bellio, C. Barbiellini Amidei, G. Capodaglio, F. Avossa, E. Narne, et al. (+4)
68 [GO] 2021―Sep―20 PC.01.11 IMPACT OF COVID-19 PANDEMIC ON COLONOSCOPY AND SURGICAL INTERVENTIONS FOR COLORECTAL CANCER IN VENETO REGION B. Germana’, S. Bellio, C. Barbiellini Amidei, G. Capodaglio, F. Avossa, E. Narne, et al. (+6)
69 [GO] 2021―Sep―20 OC.04.8 IMPACT OF COVID-19 PANDEMIC ON REFERRAL OF PATIENTS WITH LIVER DISEASE TO A LIVER TRANSPLANT CENTER G. Germani, M. Pellone, A. Ferrarese, A. Zanetto, S. Shalaby, G. Carretta, et al. (+9)
70 [GO] 2021―Sep―20 OC.06.8 THE EMERGING ROLE OF TELEMEDICINE IN GASTROENTEROLOGY DURING THE COVID-19 PANDEMIC: A STUDY ON ITS FEASIBILITY AND PATIENTS’ TRUST A. Costantino, L. Elli, L. Roncoroni, D. Noviello, F.S. Conforti, N. Nandi, et al. (+3)
71 [GO] 2021―Sep―20 AF.78 THE PARADOX OF COVID-19 PANDEMIC: EFFECT OF LOCKDOWN ON THE IMPROVEMENT OF IRRITABLE BOWEL SYNDROME SEVERITY M. Andreozzi, B. Polese, N. Mancino, V. Vaino, G. Di Giorgio, S. Rurgo, et al. (+2)
72 [GO] 2021―Sep―20 AF.39 INFLAMMATORY BOWEL DISEASE VIDEO-CONSULTING: A SATISFACTION SURVEY DURING THE SECOND WAVE OF COVID-19 PANDEMICS A. Todeschini, A. Contaldo, I. Lacavalla, E. Ierardi, A. Di Leo, M. Principi
73 [GO] 2021―Sep―20 AF.53 THE LEGACY OF COVID-19 PANDEMICS: REMOTE MONITORING OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE AS AN EFFECTIVE MANAGEMENT STRATEGY A. Busacca, E. Sinagra, L. Guida, L. Carrozza, M. Maida, S. Battaglia, et al. (+3)
74 [GO] 2021―Sep―20 AF.49 DETERMINANTS OF COVID-19 VACCINE HESITANCY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): RESULTS OF A NATIONAL SURVEY OF THE ITALIAN IBD PATIENTS’ ASSOCIATION (AMICI ONLUS) A. Costantino, D. Noviello, F.S. Conforti, M. Aloi, A. Armuzzi, F. Bossa, et al. (+12)
75 [GO] 2021―Sep―20 AF.27 COVID-19 VACCINE: A SURVEY ON HESITANCY IN PATIENTS WITH CELIAC DISEASE A. Costantino, M. Topa, L. Roncoroni, V. Lombardo, D. Stocco, A. Gramegna, et al. (+3)
76 [GO] 2021―Sep―20 PC.01.3 SEVERE ACTIVITY OF INFLAMMATORY BOWEL DISEASE IS A RISK FACTOR FOR SEVERE COVID-19: DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD) F.S. Macaluso, A. Giuliano, W. Fries, A. Viola, A. Abbruzzese, M. Cappello, et al. (+16)
77 [GO] 2021―Sep―20 AF.86 THE ANALYSIS OF ALCOHOL CONSUMPTION DURING THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 ITALIAN LOCKDOWN M. Romeo, M. Dallio, A.G. Gravina, C. Mazzarella, A. Spina, C. Loguercio, A. Federico
78 [GO] 2021―Sep―20 AF.42 SARS-COV-2 ANTIBODIES POSITIVITY IN IBD POPULATION AND CORRELATION WITH THERAPY: A PILOT STUDY C.B. Conti, E. Mainardi, S. Soro, S. Testa, A. De Silvestri, A. Drago, et al. (+2)
79 [GO] 2021―Sep―20 AF.94 IMPACT OF SARS-COV-2 INFECTION IN WAITING LIST FOR LIVER TRANSPLANTATION A. Sessa, A. Mazzola, B. Granger, L. Walkselman, M. Atif, V. Pourcher, et al. (+4)
80 [GO] 2021―Sep―20 OC.07.2 FUNCTIONAL GASTROINTESTINAL AND SOMATOFORM SYMPTOMS FIVE MONTHS AFTER SARS-COV-2 INFECTION: A CONTROLLED COHORT STUDY D. Noviello, A. Costantino, A. Muscatello, A. Bandera, D. Consonni, M. Vecchi, G. Basilisco
81 [GO] 2021―Sep―20 AF.140 ASSESSMENT OF THE EUS PROCEDURES IN A NORTH ITALIAN ENDOSCOPY UNIT DURING THE 2020 COVID PANDEMIC T. Togliani, I. Breoni, V. Davì, N. Mantovani, E. Vitetta, S. Pilati
82 [GO] 2021―Aug―09 POST COVID-19 Cholangiopathy - A Deep Dive Lakshmi Deepak Bethineedi, Tarun Kumar Suvvari
83 [GO] 2021―Jul―24 Correct use of telemedicine in gastroenterology, hepatology, and endoscopy during and after the COVID-19 pandemic: Recommendations from the Italian association of hospital gastroenterologists and endoscopists (AIGO) Andrea Costantino, Francesco Bortoluzzi, Mauro Giuffrè, Roberto Vassallo, Luigi Maria Montalbano, Fabio Monica, et al. (+5)
84 [GO] 2021―Jun―28 Reply to: “Characteristics and In-Hospital Outcomes of COVID-19 Patients with Acute or Subacute Liver Failure” walid ibrahim yousif
85 [GO] 2021―Jun―26 Safety of gastrointestinal endoscopy during the COVID-19 pandemic: A new quality indicator? Dr. Francesca Gauci, Dr. Ayrton Borg Axisa, Dr. Andrea Vella Baldacchino, Dr. Pierre Ellul
86 [GO] 2021―Jun―07 No impact of restructuring IBD-related activity during COVID-19 outbreak on patient outcomes. A single Center experience Fabiola De Biasio, Annalisa Aratari, Stefano Festa, Roberto Lorenzetti, Claudio Papi
87 [GO] 2021―May―31 Characteristics and In-Hospital Outcomes of COVID-19 Patients with Acute or Subacute Liver Failure Yiyan Zhang, Xiaozhong Guo, Zhuang Ma, Bing Wang, Hui Lu, Xingshun Qi
88 [GO] 2021―May―26 Acute splanchnic vein thrombosis in patients with COVID-19: a systematic review Giacomo Buso, Chiara Becchetti, Annalisa Berzigotti
89 [GO] 2021―Apr―30 Italian association for the study of the liver position statement on SARS-CoV2 vaccination Francesco Paolo Russo, Salvatore Piano, Raffaele Bruno, Patrizia Burra, Massimo Puoti, Mario Masarone, et al. (+4)
90 [GO] 2021―Apr―27 Endoscopy during the COVID-19 pandemic: is it time to down-grade personal protective equipment for vaccinated personnel? Luca Elli, Alessandro Rimondi, Eugenio Tontini, Andrea Gori, Maurizio Vecchi, Roberto Penagini
91 [GO] 2021―Apr―19 Reply to: “Liver fibrosis and adverse outcomes in COVID-19” Astrid Ruiz-Margáin, Alejandro Campos-Murguía, José Alberto González-Regueiro, Berenice Monserrat Román-Calleja, Deyanira Kúsulas Delint, Ricardo Ulises Macías-Rodríguez
92 [GO] 2021―Apr―02 Liver fibrosis and adverse outcomes in COVID-19 Jianmin Huang
93 [GO] 2021―Mar―27 Management of patients with Inflammatory Bowel Disease and outcomes during the first wave of the Covid-19 pandemic Anna Viola, Federica Giambò, Michele Francesco Chiappetta, Giuseppe Costantino, Socrate Pallio, Walter Fries
94 [GO] 2021―Mar―20 Factors associated with risk of COVID-19 contagion for endoscopy healthcare workers: a survey from the Italian Society of Digestive Endoscopy. Alberto Mariani, Gabriele Capurso, Giovanni Marasco, Helga Bertani, Stefano Francesco Crinò, Andrea Magarotto, et al. (+4)
95 [GO] 2021―Mar―09 Changes in digestive cancer diagnosis during the SARS-CoV-2 pandemic in Italy: a nationwide survey Elisabetta BUSCARINI, Antonio BENEDETTI, Fabio MONICA, Luigi PASQUALE, Francesco BUTTITTA, Michela CAMELETTI, et al. (+50)
96 [GO] 2021―Feb―26 Could SARS-CoV-2 be associated with emphysematous gastritis? Sonsoles Garrosa-Muñoz, Jaime López-Sánchez, Luis Miguel González-Fernández, Luis Muñoz-Bellvís
97 [GO] 2021―Feb―23 The Fibrosis-4 index is associated with Intensive Care Unit (ICU) admission in middle-aged patients with COVID-19 E. Biliotti, P. Piselli, U. Visco Comandini, R. Lionetti, C. Taibi, L. Vincenzi, et al. (+14)
98 [GO] 2021―Feb―23 COVID-19 and Solid Organ Transplantation (SOT) in Italy: A web-survey F. Galiandro, S. Agnes, F. Giovinazzo, A. Vitale, R. Romagnoli, C. Amarelli, et al. (+4)
99 [GO] 2021―Feb―23 High levels of transaminases at admission predict a severe disease course in COVID-19 hospitalized patients F. Pelizzaro, M.P. Kitenge, F. Maran, E. Cocconcelli, E. Balestro, P. Spagnolo, et al. (+2)
100 [GO] 2021―Feb―23 No impact of the 2020 COVID-19 lockdown on hospitalization rates for alcoholic liver disease in a large tertiary hospital in Milan C. Masetti, F. Colapietro, N. Pugliese, F. De Fazio, A. Voza, I Bianchi, et al. (+3)
101 [GO] 2021―Feb―23 Liver Transplantation during the COVID-19 pandemic: A quantitative model balancing individual patient benefit against population healthcare needs U. Cillo, A. Vitale, M.L. Volk, A.C. Frigo, P. Feltracco, A. Cattelan, et al. (+7)
102 [GO] 2021―Feb―23 Hepatocellular liver injury in hospitalized patients affected by COVID-19: Different factors at different time points M. Leo, A. Galante, A. Pagnamenta, F.R. Ponziani, A. Gasbarrini, A. De Gottardi
103 [GO] 2021―Feb―23 Liver transplant recipients with Covid-19: results from an Italian multicenter cohort C. Mazzarelli, R. Viganò, G. Perricone, M. Merli, L. Pasulo, F. Invernizzi, et al. (+9)
104 [GO] 2021―Feb―23 Liver transplant candidates and SARS-CoV-2 infection: Results from an Italian multicenter cohort G. Perricone, R. Vigano, C. Mazzarelli, G. Travi, L. Pasulo, F. Invernizzi, et al. (+10)
105 [GO] 2021―Feb―23 Metabolic alterations and hepatic fibrosis impact on severity of SARS-COV2 infection R. Lombardi, A. Cespiati, V. La Mura, F. Iuculano, G. Sigon, G. Pallini, et al. (+9)
106 [GO] 2021―Feb―23 Associated screening for HCV and SARS-Cov2 infection in an urban area of Southern Italy: the “Casola di Napoli” cohort study C. Coppola, M. Masarone, M. Bartoli, L. Staiano, P. Torre, M. Conforti, et al. (+3)
107 [GO] 2021―Feb―21 Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients Fabio Del Zompo, Flavio De Maio, Francesco Santopaolo, Rosalba Ricci, Maurizio Pompili, Francesca Romana Ponziani
108 [GO] 2021―Feb―03 Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19 Alejandro Campos-Murguía, Berenice Monserrat Román-Calleja, Israel Vicente Toledo-Coronado, José Alberto González-Regueiro, Alberto Adrián Solís-Ortega, Deyanira Kúsulas-Delint, et al. (+12)
109 [GO] 2021―Jan―15 Successful coping with SARS-CoV-2 infection of adult celiac patients assessed by telemedicine Gloria Galli, Gianluca Esposito, Emanuele Dilaghi, Bruno Annibale, Edith Lahner, Laura Conti
110 [GO] 2021―Jan―10 Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs Fabrizio Bossa, Sonia Carparelli, Anna Latiano, Orazio Palmieri, Francesca Tavano, Anna Panza, et al. (+12)
111 [GO] 2020―Dec―26 COVID-19 in IBD: the experience of a single tertiary IBD center Prof Fernando Rizzello, Carlo Calabrese, Marco Salice, Lucia Calandrini, Hana Privitera, Laura Melotti, et al. (+11)
112 [GO] 2020―Dec―26 Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group Serena Arrigo, Patrizia Alvisi, Claudia Banzato, Matteo Bramuzzo, Rosaria Celano, Fortunata Civitelli, et al. (+19)
113 [GO] 2020―Dec―18 Management of digestive cancers during the COVID-19 second wave: A French intergroup point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR) David Tougeron, Pierre Michel, Astrid Lièvre, Michel Ducreux, Sébastien Gaujoux, Boris Guiu, et al. (+8)
114 [GO] 2020―Dec―13 Management of gastrointestinal tuberculosis during COVID pandemic: Lessons for posterity Jayendra Shukla, Anuraag Jena, Harjeet Singh, Harshal S. Mandavdhare, Usha Dutta, Vishal Sharma
115 [GO] 2020―Nov―11 Does MAFLD really increase the severity of COVID-19? Jonny Karunia Fajar, Bogi Pratomo Wibowo, Gheavita Chandra Dewi, Adi Putra Rahmadi, Meike Tiya Kusuma
116 [GO] 2020―Nov―05 COVID-19 and Pneumatosis Intestinalis: An Early Sign of Intestinal Ischemia Wesam Hassan, Haidi Karam-Allah Ramadan
117 [GO] 2020―Nov―05 Trust in telemedicine from IBD outpatients during the COVID-19 pandemic A. Costantino, D. Noviello, S. Mazza, R. Berté, F. Caprioli, M. Vecchi
118 [GO] 2020―Nov―05 Reply to "Does MAFLD really increase the severity of COVID-19?" Lu Pan, Pan Huang, Xia Xie, Jiachen Xu, Dawei Guo, Yuan Jiang
119 [GO] 2020―Oct―23 Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: a position paper on behalf of the SIGENP IBD Working Group Serena Arrigo, Patrizia Alvisi, Claudia Banzato, Matteo Bramuzzo, Fortunata Civitelli, Antonio Corsello, et al. (+22)
120 [GO] 2020―Oct―19 Fecal calprotectin levels in COVID-19: Lessons from a systematic review on its use in inflammatory bowel disease during the pandemic Anuraag Jena, Praveen Kumar-M, Anupam Kumar Singh, Vishal Sharma
121 [GO] 2020―Oct―14 Low Risk of Transmission of SARS-CoV2 and Effective Endotherapy for Gastrointestinal Bleeding Despite Challenges Supports Resuming Optimum Endoscopic Services Ashish Agarwal, Sudipta Dhar Chowdhury, Sanjeev Sachdeva, Vivek Saraswat, Rakesh Kochhar, Anoop Saraya
122 [GO] 2020―Oct―08 Endoscopic ultrasound-guided gastro-enteric anastomosis in the COVID era: May the pandemic emphasize the benefit? Alessandro Fugazza, Marco Spadaccini, Stefania Bramanti, Carlo Castoro, Alessandro Repici, Andrea Anderloni
123 [GO] 2020―Oct―06 Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection Timotius Ivan Hariyanto, Ignatius Bima Prasetya, Andree Kurniawan
124 [GO] 2020―Oct―03 How an endoscopy unit changed and was partially converted into an ICU during COVID-19 emergency in a tertiary referral hospital of Northern Italy Vincenzo Giorgio Mirante, Giorgio Mazzi, Gerolamo Bevivino, Francesca Parmeggiani, Giorgio Iori, Romano Sassatelli
125 [GO] 2020―Sep―29 Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study Gianluca Ianiro, Stefano Bibbò, Luca Masucci, Gianluca Quaranta, Serena Porcari, Carlo Romano Settanni, et al. (+5)
126 [GO] 2020―Sep―29 Splanchnic vein thrombosis in COVID-19: A Review of Literature Balraj Singh, Parminder Kaur, Michael Maroules
127 [GO] 2020―Sep―22 COVID-19 and intestinal inflammation: role of fecal calprotectin Veronica Ojetti, Angela Saviano, Marcello Covino, Nicola Acampora, Eliana Troiani, Francesco Franceschi
128 [GO] 2020―Sep―19 Systematic review on failure to adhere to IBD therapies during the COVID-19 pandemic: Correct information is crucial Anuraag Jena, Anupam Kumar Singh, Praveen Kumar-M, Vishal Sharma, Shaji Sebastian
129 [GO] 2020―Sep―17 Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis Lu Pan, Pan Huang, Xia Xie, Jiachen Xu, Dawei Guo, Yuan Jiang
130 [GO] 2020―Sep―16 Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis Vincenzo Cardinale, Gabriele Capurso, Gianluca Ianiro, Antonio Gasbarrini, Paolo Giorgio Arcidiacono, Domenico Alvaro
131 [GO] 2020―Sep―06 COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW OF CLINICAL DATA Fabio Salvatore Macaluso, Ambrogio Orlando
132 [GO] 2020―Sep―04 Hospitalized coronavirus disease-2019 (COVID-19) patients with gastrointestinal symptoms have improved survival to discharge Benjamin D. Renelus, Neil Khoury, Karthik Chandrasekaran, Ezana Bekele, William M. Briggs, Daniel S. Jamorabo
133 [GO] 2020―Aug―31 URGENT SURGERY FOR INFLAMMATORY BOWEL DISEASES DURING THE COVID-19 OUTBREAK IN A HIGH INCIDENCE AREA - EXPERIENCE FROM A HIGH-VOLUME CENTRE Fiorenzo Botti, Stefano Mazza, Stefano Costa, Elisa Farina, Ludovica Baldari, Matteo Prati
134 [GO] 2020―Aug―29 Covid-19 post-lockdown: a transparent box, used as protective equipment in gastroscopy. A test of feasibility and efficacy Ofir Har-Noy, Lev Lichtenstein, Evgeny Landa, Zvika Marcus, Gil Ovadia, Jorge-Shmuel Delgado
135 [GO] 2020―Aug―25 Does interval time between liver transplant and COVID-19 infection make the difference? Vincenzo Buscemi, Riccardo De Carlis, Andrea Lauterio, Marco Merli, Massimo Puoti, Luciano De Carlis
136 [GO] 2020―Aug―10 Systemic inflammation as fuel for acute liver injury in COVID-19 Maria Effenberger, Christoph Grander, Felix Grabherr, Andrea Griesmacher, Thomas Ploner, Frank Hartig, et al. (+6)
137 [GO] 2020―Jul―27 Reply to comment: Screening for active COVID-19 infection prior to biologic therapy in IBD patients: primum non nŏcēre Fabiana Zingone, Andrea Buda, Edoardo Savarino
138 [GO] 2020―Jul―27 Safe administration of corticosteroids in severe ulcerative colitis and active SARS-CoV2 infection Pierre Mayer, Antonio Saviano, Loïc Kassegne, Thomas F. Baumert, Jean-Marie Reimund, François Habersetzer
139 [GO] 2020―Jul―23 Digestive and Liver Diseases and the COVID-19 Pandemic Roberto de Franchis
140 [GO] 2020―Jul―21 How endoscopy centers prepare to reopen after the acute COVID-19 pandemic interruption of activity V Castagna, E Armellini, F Pace, C Alvisi, S Agazzi, A Amato, et al. (+14)
141 [GO] 2020―Jul―21 Will “Video kill the Radiostar” or is zooming just a pandemic transient Hype? Some cautionary notes Guilherme Macedo
142 [GO] 2020―Jul―19 NONINVASIVE MONITORING OF INFLAMMATORY BOWEL DISEASE IN THE POST COVID-19 ERA Olga Maria Nardone, Antonio Rispo, Fabiana Castiglione
143 [GO] 2020―Jul―15 Trends in cirrhosis hospitalizations during the COVID-19 pandemic R. Gaspar, R. Liberal, Catarina Castelo Branco, G. Macedo
144 [GO] 2020―Jul―14 Prevalence of functional gastrointestinal disorders in children with celiac disease during the COVID-19 lockdown Francesca Fiori Nastro, Carlo Tolone, Maria Rosaria Serra, Daniela Pacella, Angelo Campanozzi, Caterina Strisciuglio
145 [GO] 2020―Jul―12 SARS-CoV-2 infection in severe pediatric Crohn's disease. What about anti-tumor necrosis factor α therapy? Bardasi Giulia, Alvisi Patrizia
146 [GO] 2020―Jul―10 Assessing the Impact of COVID-19 on the management of patients with liver diseases: A national survey by the Italian Association for the Study of the Liver Alessio Aghemo, Mario Masarone, Sara Montagnese, Salvatore Petta, Francesca Romana Ponziani, Francesco Paolo Russo
147 [GO] 2020―Jul―10 Reorganization of the Functional Gastrointestinal Disorders Unit during the SARS-CoV-2 Outbreak - Practical Recommendations Matteo Ghisa, Brigida Barberio, Greta Lorenzon, Fabiana Zingone, Edoardo Savarino
148 [GO] 2020―Jul―07 Children and Fecal SARS-CoV-2 shedding: Just the Tip of the Iceberg of Italian COVID-19 outbreak? Salvatore Oliva, Salvatore Cucchiara, Franco Locatelli
149 [GO] 2020―Jul―06 Unchanged surgical management of patients with Cholangiocarcinoma during the COVID-19 pandemic Enrico Gringeri, Martina Gambato, Alessandro Furlanetto, Mattia Ballo, Eleonora Nieddu, Umberto Cillo
150 [GO] 2020―Jul―03 Patients with COVID-19 present with low plasma citrulline concentrations that associate with systemic inflammation and gastrointestinal symptoms Mathieu Uzzan, Damien Soudan, Katell Peoch, Emmanuel Weiss, Olivier Corcos, Xavier Treton
151 [GO] 2020―Jun―29 Performing endoscopy in a reorganised gastroenterology department during pandemic lockdown Renato Medas, Patrícia Andrade, Pedro Moutinho-Ribeiro, Guilherme Macedo
152 [GO] 2020―Jun―23 Who comes first: rescheduling endoscopic activity after the acute phase of the Covid 19 pandemic Giulia Tripodi, Emanuele Dilaghi, Silvia Fanella, Vito Domenico Corleto, Emilio Di Giulio
153 [GO] 2020―Jun―19 Planning Phase Two for Endoscopic Units in Northern Italy after the COVID-19 lockdown: an exit strategy with a lot of critical issues and a few opportunities Gianpiero Manes, Alessandro Repici, Franco Radaelli, Cristina Bezzio, Matteo Colombo, Simone Saibeni
154 [GO] 2020―Jun―18 The management of Inflammatory Bowel Diseases in the era of COVID-19 pandemic: when “non-urgent” does not mean “deferrable” Daniela Pugliese, Claudio Papi, Giuseppe Privitera, Annalisa Aratari, Stefano Festa, Alessandro Armuzzi
155 [GO] 2020―Jun―16 Delivery of care remotely through telemedicine in celiac disease: Thinking beyond COVID-19 M. Ines Pinto-Sanchez, Benjamin Lebwohl
156 [GO] 2020―Jun―16 Five recommendations for loco-regional treatments of hepatocellular carcinoma during the COVID-19 pandemic Roberto Santambrogio, Elisa Galfrascoli, Marco Antonio Zappa
157 [GO] 2020―Jun―15 Reorganization of the endoscopic activity of Cancer Institutes during phase II of the Covid-19 emergency Fiori Giancarla, Trovato Cristina, Staiano Teresa, Magarotto Andrea, Stigliano Vittoria, Masci Enzo, et al. (+6)
158 [GO] 2020―Jun―15 COVID-19-related thrombotic microangiopathy in a cirrhotic patient A. Airoldi, G. Perricone, S. De Nicola, C. Molisano, P. Tarsia, L.S. Belli
159 [GO] 2020―Jun―13 LOW FREQUENCY OF COVID-19 IN INFLAMMATORY BOWEL DISEASES Irene Marafini, Silvia Salvatori, Giorgia Sena, Emma Calabrese, Livia Biancone, Giovanni Monteleone
160 [GO] 2020―Jun―13 THE FORGOTTEN VICTIMS OF THE COVID-19 PANDEMIC Harold Benites-Goñi, Jéssica Alférez-Andía, Fernando Barreda-Bolaños
161 [GO] 2020―Jun―13 Medical care of atrophic gastritis patients during COVID-19 pandemic: results of telemedicine in a referral center Gianluca Esposito, Emanuele Dilaghi, Gloria Galli, Laura Conti, Bruno Annibale, Edith Lahner
162 [GO] 2020―Jun―13 LIGHTS AND SHADOWS OF SARS-CoV-2 INFECTION RISK ASSESSMENT IN ENDOSCOPY Roberto Grassia, Sophie Testa, Annalisa De Silvestri, Andrea Drago, Fabrizio Cereatti, Clara Benedetta Conti
163 [GO] 2020―Jun―13 Impact of SARS-CoV-2 on a high volume endoscopy centre in Italy Ivo Boškoski, Silvia Pecere, Vincenzo Bove, Federico Barbaro, Vincenzo Perri, Guido Costamagna
164 [GO] 2020―Jun―11 Ref. No. DLD-20-852: Onset of ulcerative colitis during SARS-Cov-2 infection Emma Calabrese, Francesca Zorzi, Giovanni Monteleone, Giovanna Del Vecchio Blanco
165 [GO] 2020―Jun―10 Intestinal ischemia in the COVID-19 era Lorenzo Norsa, Clarissa Valle, Denise Morotti, Bonaffini Pietro Andrea, Amedeo Indriolo, Sonzogni Aurelio
166 [GO] 2020―May―29 Fecal Calprotectin and RT-PCR from both nasopharyngeal swab and stool samples prior to treatment decision in IBD patients during CoVID-19 outbreak. Dr Cherradi Younes
167 [GO] 2020―May―29 Will the COVID-19 pandemic affect HCV disease burden? Loreta A. Kondili, Andrea Marcellusi, Stephen Ryder, Antonio Craxì
168 [GO] 2020―May―26 Screening for active COVID-19 infection prior to biologic therapy in IBD patients: Let's not increase our uncertainty without reducing our concerns Stefano Festa, Annalisa Aratari, Fabiola De Biasio, Federica Fascì-Spurio, Claudio Papi
169 [GO] 2020―May―23 Negative-pressure box under continuous suction for shielding against aerosols produced by patients with COVID-19 during abdominal ultrasound-guided intervention Joji Tani, Hideki Kobara, Noriko Nishiyama, Tsutomu Masaki
170 [GO] 2020―May―23 Impact of COVID-19 outbreak on clinical practice and training of young gastroenterologists: a European Survey Giovanni Marasco, Olga Maria Nardone, Marcello Maida, Ivo Boskoski, Luca Pastorelli, Franco Scaldaferri
171 [GO] 2020―May―19 Systematic analysis of acute liver injury during SARS-CoV-2 infection Jose D. Debes, Chimaobi M. Anugwom, Elizabeth S. Aby
172 [GO] 2020―May―16 Redesign of a GI endoscopy unit during the COVID-19 emergency: A practical model Vincenzo Cennamo, Marco Bassi, Stefano Landi, Pasquale Apolito, Stefania Ghersi, Emanuele Dabizzi, et al. (+10)
173 [GO] 2020―May―16 A negative fallout of COVID-19 lockdown in Italy: life-threatening delay in the diagnosis of celiac disease Giulia N. Catassi, Martina Vallorani, Federica Cerioni, Elena Lionetti, Carlo Catassi
174 [GO] 2020―May―16 ANALYSIS OF PATIENTS ATTITUDE TO UNDERGO URGENT ENDOSCOPIC PROCEDURES DURING COVID-19 OUTBREAK IN ITALY E Armellini, A Repici, C Alvisi, M Dinelli, P Gambitta, G Manes, et al. (+8)
175 [GO] 2020―May―16 “Impact of the COVID-19 pandemic on Gastroenterology Divisions in Italy: a national survey” M. Maida, S. Sferrazza, E. Savarino, L. Ricciardiello, A. Repici, F. Morisco, et al. (+10)
176 [GO] 2020―May―16 COVID-19 pandemic perception in adults with celiac disease: an impulse to implement the use of telemedicine Monica Siniscalchi, Fabiana Zingone, Edoardo Vincenzo Savarino, Anna D'Odorico, Carolina Ciacci
177 [GO] 2020―May―15 COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR) Frederic Di Fiore, Olivier Bouché, Come Lepage, David Sefrioui, Alice Gangloff, Lilian Schwarz, et al. (+8)
178 [GO] 2020―May―15 No Need of Transforming Gastroenterology Units to COVID Units at the Time of SARS-COV2 Infection - A Single-Center Analysis from Northern Italy Fabiana Zingone, Cesare Casadei, Fabio Farinati, Edoardo Savarino
179 [GO] 2020―May―08 Clinical characteristics of Coronavirus Disease (COVID-19) patients with gastrointestinal symptoms: A report of 164 cases Hu Zhang, Yu-Sheng Liao, Jing Gong, Jing Liu, Xi Xia, Heng Zhang
180 [GO] 2020―May―06 A WEB-BASED GROUP TREATMENT FOR PATIENTS WITH ALCOHOLIC LIVER DISEASES AT THE TIME OF THE COVID-19 PANDEMIC Matteo Massimo Bossi, Manuel Tufoni, Giacomo Zaccherini, Agnese Antognoli, Marco Domenicali, Paolo Caraceni
181 [GO] 2020―Apr―29 SARS-CoV-2 and gastrointestinal tract: the dark side of the pandemic Roberto Grassia, Sophie Testa, Angelo Pan, Clara Benedetta Conti
182 [GO] 2020―Apr―27 Endoscopy during the Covid-19 outbreak: experience and recommendations from a single center in a high-incidence scenario Luca Elli, Alessandro Rimondi, Lucia Scaramella, Matilde Topa, Maurizio Vecchi, Davide Mangioni, et al. (+2)
183 [GO] 2020―Apr―18 EUS-guided gallbladder drainage during a pandemic crisis - How the COVID-19 outbreak could impact interventional endoscopy Dr. Andrea Lisotti, Prof. Pietro Fusaroli
184 [GO] 2020―Apr―10 Screening for Active COVID-19 Infection and Immunization Status Prior to Biologic Therapy in IBD Patients at the Time of the Pandemic Outbreak Fabiana Zingone, Andrea Buda, Edoardo Vincenzo Savarino
185 [GO] 2020―Apr―08 Covid-19 and cancer patients: Choosing wisely is the key Renato Cannizzaro, Fabio Puglisi
186 [GO] 2020―Apr―08 Challenges in paediatric inflammatory bowel diseases in the COVID-19 time Valeria Dipasquale, Salvatore Cucchiara, Massimo Martinelli, Erasmo Miele, Marina Aloi, Claudio Romano
 [1] 

186 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.024 sec